AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

483 Mitsubishi Tanabe Pharma Development America, Oct 2021

$179 - Available for instant download

FDA investigators audited the Mitsubishi Tanabe Pharma Development America - Jersey City , NJ, United States facility and issued inspectional observation (via FDA 483) on 15 Oct 2021.

Product Details

  • Inspection end: 15 Oct 2021
  • Location: Jersey City, United States
  • FEI: 3003777563
Mitsubishi Tanabe Pharma Development America FDA inspection 483 Oct 2021